The clinical significance of HER2 protein amplification/expression in urinary bladder lesion.

Hammam, Olfat; Nour, Hani H; Mosaad, Maha; Akl, Maha; Khalil, Heba; Al Ganzory, Hossam; Hindawi, Ali

Hammam, Olfat; Nour, Hani H; Mosaad, Maha; Akl, Maha; Khalil, Heba; Al Ganzory, Hossam; Hindawi, Ali.

Afiliación

Hammam O; Pathology Department, Theodor Bilharz Research Institute, Giza Egypt.
Nour HH; Urology Department, Theodor Bilharz Research Institute, Giza Egypt.
Mosaad M; Pathology Department, Kasr El Aini School of Medicine, Cairo University, Egypt.
Akl M; Pathology Department, Theodor Bilharz Research Institute, Giza Egypt.
Khalil H; Pathology Department, Kasr El Aini School of Medicine, Cairo University, Egypt.
Al Ganzory H; Urology Department, Theodor Bilharz Research Institute, Giza Egypt.
Hindawi A; Pathology Department, Kasr El Aini School of Medicine, Cairo University, Egypt.

Arab J Urol ; 13(2): 146-52, 2015 Jun.

Article en En | MEDLINE | ID: mdl-26413337

Palabras clave

(N)MI, (non-)muscle-invasive; Bladder cancer; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridisation; HER2; IHC, immunohistochemical; SCC, squamous cell carcinoma; Schistosomiasis; Squamous; TURBT, transurethral resection of bladder tumour; Transitional

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Arab J Urol Año: 2015 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Arab J Urol Año: 2015 Tipo del documento: Article